Search Results 41-50 of 17901 for Multiple system atrophy
The purpose of this study is to evaluate the safety and tolerability of YA-101. Participation eligibility. Participant eligibility includes age, gender, type ...
Multiple system atrophy. Departments and specialties. Mayo Clinic has one of the largest and most experienced practices in the United States, with campuses in ...
Key Inclusion Criteria: * The participant has a diagnosis of clinically established multiple system atrophy parkinsonian type (MSA-P) or multiple system ...
Inclusion Criteria: The participant is capable of communicating with the site staff. The participant is able to read and understand the Informed Consent ...
The purpose of this study is to compare the effectiveness of BHV-3241 versus placebo in subjects with Multiple System Atrophy. Participation eligibility.
The purpose of this study is to evaluate the effectiveness of Lu AF82422 on disease progression in patients with Multiple System Atrophy (MSA). Participation ...
... Multiple System Atrophy Rating Scale (UMSARS) Part I, minus the sexual function item, with collapse of the normal and mild ratings on each item.
The purpose of this study is to determine the effectiveness of Rifampicin in slowing or reversing the progression of multiple system atrophy. Participation ...
... Multiple System Atrophy. Cerebellum. 2024 Dec 5; 24 (1):2 Epub 2024 Dec 05. View PubMed; Christenson PR, Jeong H, Li M, Ahn H, Schmeichel AM, Misra P, Li D ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Your donation powers the future of medicine and helps save lives.